DUTCH Weight Control in Atrial Fibrillation Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 280 participants.
Also called NCT06184633
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 280 participants
- Sponsor
- Registry
-
NCT06184633
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06184633. Randomized; triple masking; primary purpose treatment. Start 2024-07-21 (actual); primary completion 2027-04-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DUTCH Weight Control in Atrial Fibrillation Study
- Acronym
- DUTCH-WAIST
- Condition
- Atrial Fibrillation
- Condition
- Obesity
- Condition
- Weight Loss
- Intervention (Drug)
- Semaglutide 3.2 MG/ML
- Intervention (Drug)
- Placebo
- Lead sponsor
- Rijnstate Hospital
Record details
- Record id
cardio:ct-nct06184633- Content hash
cdefc81cb36ac2d5002f214d5b8c6aee168e5d0fe6a5cd457fe103dddeb5fb41